Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies
Authors
Keywords
-
Journal
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Volume 75, Issue 10, Pages 936-945
Publisher
Oxford University Press (OUP)
Online
2016-08-17
DOI
10.1093/jnen/nlw070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
- (2016) Carla Abdelnour et al. MOVEMENT DISORDERS
- Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
- (2015) Lauren Walker et al. ACTA NEUROPATHOLOGICA
- PART is part of Alzheimer disease
- (2015) Charles Duyckaerts et al. ACTA NEUROPATHOLOGICA
- Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
- (2015) Gabor G. Kovacs et al. ACTA NEUROPATHOLOGICA
- Inhibition of amyloid-β plaque formation by α-synuclein
- (2015) Teresa Bachhuber et al. NATURE MEDICINE
- Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases
- (2015) C. Ruffmann et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Clinicians' ability to diagnose dementia with Lewy bodies is not affected by -amyloid load
- (2015) P. Tiraboschi et al. NEUROLOGY
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- Alzheimer’s disease-related plaques in nondemented subjects
- (2014) Adila Elobeid et al. Alzheimers & Dementia
- Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
- (2014) Cassia R Overk et al. Molecular Neurodegeneration
- The spectrum of cognitive impairment in Lewy body diseases
- (2014) Jennifer G. Goldman et al. MOVEMENT DISORDERS
- The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
- (2013) Caroline H Williams-Gray et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pedunculopontine Cholinergic Cell Loss in Hallucinating Parkinson Disease Patients but Not in Dementia With Lewy Bodies Patients
- (2013) Dagmar Hyacintha Hepp et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies
- (2013) Martí Colom-Cadena et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Neuropathology of dementia in a large cohort of patients with Parkinson's disease
- (2013) Judit Horvath et al. PARKINSONISM & RELATED DISORDERS
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia
- (2012) Paul T. Kotzbauer et al. ARCHIVES OF NEUROLOGY
- Brain amyloid and cognition in Lewy body diseases
- (2012) Stephen N. Gomperts et al. MOVEMENT DISORDERS
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- Examining the mechanisms that link β-amyloid and α-synuclein pathologies
- (2012) Samuel E Marsh et al. Alzheimers Research & Therapy
- Neuropathology underlying clinical variability in patients with synucleinopathies
- (2011) Glenda M. Halliday et al. ACTA NEUROPATHOLOGICA
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease
- (2011) Glenda M. Halliday et al. JOURNAL OF NEURAL TRANSMISSION
- Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia
- (2010) Hiroshige Fujishiro et al. NEUROSCIENCE LETTERS
- Levodopa response in dementia with lewy bodies: A 1-year follow-up study
- (2010) Claudio Lucetti et al. PARKINSONISM & RELATED DISORDERS
- Assessment of β-amyloid deposits in human brain: a study of the BrainNet Europe Consortium
- (2009) Irina Alafuzoff et al. ACTA NEUROPATHOLOGICA
- The progression of pathology in Parkinson's disease
- (2009) Glenda Margaret Halliday et al. Annals of the New York Academy of Sciences
- Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
- (2008) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- The progression of pathology in longitudinally followed patients with Parkinson’s disease
- (2008) Glenda Halliday et al. ACTA NEUROPATHOLOGICA
- RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy-Related Pathology in the Dementia Patient
- (2008) James B. Leverenz et al. BRAIN PATHOLOGY
- Systematic Appraisal Using Immunohistochemistry of Brain Pathology in Aged and Demented Subjects
- (2008) Leena Aho et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Cerebral amyloid angiopathy in Lewy body disease
- (2008) K. A. Jellinger et al. JOURNAL OF NEURAL TRANSMISSION
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- (2008) P Edison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Striatal β-Amyloid Deposition in Parkinson Disease With Dementia
- (2008) Michail E. Kalaitzakis et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Imaging amyloid deposition in Lewy body diseases
- (2008) S. N. Gomperts et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started